Title : The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease.

Pub. Date : 2016 Oct 14

PMID : 27754444






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Additionally, reduction of proprotein convertase subtilisin/kexin 9 (PCSK9) expression and DNA methylation are also involved in pharmacological mechanisms of berberine in the treatment of NAFLD. Berberine proprotein convertase subtilisin/kexin type 9 Homo sapiens
2 Additionally, reduction of proprotein convertase subtilisin/kexin 9 (PCSK9) expression and DNA methylation are also involved in pharmacological mechanisms of berberine in the treatment of NAFLD. Berberine proprotein convertase subtilisin/kexin type 9 Homo sapiens